Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 193

The DOI matches its Crossref record.

A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries

Open access
Curtis, Jeffrey R., Jain, Archana, Askling, Johan, Bridges, S. Louis, Carmona, Loreto, Dixon, William, Finckh, Axel, Hyrich, Kimme, Greenberg, Jeffrey D., Kremer, Joel, Listing, Joachim, Michaud, Kaleb, Mikuls, Ted, Shadick, Nancy, Solomon, Daniel H., Weinblatt, Michael E., Wolfe, Fred, Zink, Angela · 2010 · Seminars in Arthritis and Rheumatism

Abstract

Purpose To provide a qualitative comparison of selected US and European rheumatoid arthritis (RA) biologics registries and cohorts including ARTIS, BIOBADASER, BSRBR, BRASS, CLEAR, CORRONA, NDB, RABBIT, SCQM, and VARA. Randomized controlled trials (RCTs) have demonstrated the efficacy of biologic agents in treatment of rheumatic diseases. However, results from RCTs may not be generalizable to clinical practice because of their strict inclusion and exclusion criteria. Assessment of safety using RCT data also is limited by short duration of follow-up and relatively small sample sizes which generally preclude analysis of longer-term outcomes and rare adverse events. In rheumatology, various observational cohorts and registries have been created to complement information obtained from RCTs, some with the primary purpose of monitoring effectiveness and safety of biologic agents. Most registries are either drug based or disease based. These registries include patients with a variety of rheumatic diseases including RA. A careful comparison of these registries, as provided in this article, can provide a basis for understanding the many similarities and differences inherent in their design, as well as societal context and content, all of which can significantly impact their results and comparisons across registers. Summary The increasing use of biologic agents for treatment of rheumatic diseases has raised important questions about cost, safety and effectiveness of these agents. The unique and variable features of patient populations and registry designs in Europe and the U.S. provide valuable and complementary data on comparative effectiveness and safety of biologic agents to what can be derived from RCTs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semarthrit.2010.03.003

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 193

Metadata

Authors
Curtis, J. R., Jain, A., Askling, J., Bridges, S. L., Carmona, L., Dixon, W., Finckh, A., Hyrich, K., Greenberg, J. D., Kremer, J., Listing, J., Michaud, K., Mikuls, T., Shadick, N., Solomon, D. H., Weinblatt, M. E., Wolfe, F., & Zink, A.
Venue
Seminars in Arthritis and Rheumatism
Publisher
Elsevier BV
Published
2010-08
Volume
40
Issue
1
Pages
2-14.e1
ISSN
0049-0172 (ISSN-L)
OpenAlex
W2118378094
Cited by
193
References
0
FWCI
11.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries. https://app.cochat.ai/papers/10.1016/j.semarthrit.2010.03.003
The paper
Curtis, J. R., Jain, A., Askling, J., Bridges, S. L., Carmona, L., Dixon, W., Finckh, A., Hyrich, K., Greenberg, J. D., Kremer, J., Listing, J., Michaud, K., Mikuls, T., Shadick, N., Solomon, D. H., Weinblatt, M. E., Wolfe, F., & Zink, A. (2010). A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries. Seminars in Arthritis and Rheumatism. https://doi.org/10.1016/j.semarthrit.2010.03.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.